Current and future treatments of alopecia areata and trichotillomania in children

References

• Tosti A, Bellavista S, Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J Am Acad Dermatol. 2006;55(3):438–441.
   PubMed Web of Science ®Google Scholar
• Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366(16):1515–1525.
   PubMed Web of Science ®Google Scholar
• Messenger AG, McKillop J, Farrant P, et al. British Association of Dermatologists’ guidelines for the management of alopecia areata. Br J Dermatol. 2012;166(5):916–926.
   PubMed Web of Science ®Google Scholar
• Petukhova L, Cabral RM, Mackay Wiggan J, et al. The genetics of alopecia areata: what’s new and how will it help our patients? Dermatol Ther. 2011;24:326–336.
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, Pazzaglia M, et al. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol. 2003;49(1):96–98.
   PubMed Web of Science ®Google Scholar
• Tosti A, Iorizzo M, Botta GL, et al. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. J Eur Acad Dermatol Venereol. 2006;20(10):1243–1247.
   PubMed Web of Science ®Google Scholar
• Lenane P, Macarthur C, Parkin PC, et al. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children: a randomized clinical trial. JAMA Dermatol. 2014;150(1):47–50.
   PubMed Web of Science ®Google Scholar
• Tan E, Tay YK, Giam YC. A clinical study of childhood alopecia areata in Singapore. Pediatr Dermatol. 2002;19(4):298–301.
   PubMed Web of Science ®Google Scholar
• Chang KH, Rojhirunsakool S, Goldberg LJ. Treatment of severe alopecia areata with intralesional steroid injections. J Drugs Dermatol. 2009;8(10):909–912.
   PubMed Web of Science ®Google Scholar
• Hubiche T, Léauté-Labrèze C, Taïeb A, et al. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol. 2008;158(5):1136–1137.
   PubMed Web of Science ®Google Scholar
• Smith A, Trüeb RM, Theiler M, et al. High relapse rates despite early intervention with intravenous methylprednisolone pulse therapy for severe childhood alopecia areata. Pediatr Dermatol. 2015;32(4):481–487.
   PubMed Web of Science ®Google Scholar
• Friedland R, Tal R, Lapidoth M, et al. Pulse corticosteroid therapy for alopecia areata in children: a retrospective study. Dermatology. 2013;227(1):37–44.
   PubMed Web of Science ®Google Scholar
• Lalosevic J, Gajic-Veljic M, Bonaci-Nikolic B, et al. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study. Dermatol Ther. 2015;28(5):309–317.
   PubMed Web of Science ®Google Scholar
• Kuin RA, Spuls PI, Limpens J, et al. Diphenylcyclopropenone in patients with alopecia areata. A critically appraised topic. Br J Dermatol. 2015;173(4):896–909.
   PubMed Web of Science ®Google Scholar
• Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol. 1983;63(1):49–52.
   PubMed Web of Science ®Google Scholar
• Rokhsar CK, Shupack JL, Vafai JJ, et al. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol. 1998;39(5Pt1):751–761.
   PubMed Web of Science ®Google Scholar
• Van der Steen PH, van Baar HM, Happle R, et al. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol. 1991;24(2Pt1):227–230.
   PubMed Web of Science ®Google Scholar
• MacDonald Hull SP, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol. 1991;125(2):164–168.
   PubMed Web of Science ®Google Scholar
• Tosti A, Guidetti MS, Bardazzi F, et al. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol. 1996;35(2Pt1):199–201.
   PubMed Web of Science ®Google Scholar
• Schuttelaar MLA, Hamstra JJ, Plinck EPB, et al. Alopecia areata in children: treatment with diphencyprone. Br J Dermatol. 1996;135(4):581–585.
   PubMed Web of Science ®Google Scholar
• Schmoeckel C, Weissmann I, Plewig G, et al. Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol. 1979;115(10):1254–1255.
   PubMedGoogle Scholar
• Durdu M, Özcan D, Baba M, et al. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. J Am Acad Dermatol. 2015;72(4):640–650.
   PubMed Web of Science ®Google Scholar
• Park KY, Jang WS, Son IP, et al. Combination therapy with cyclosporine and psoralen plus ultraviolet a in the patients with severe alopecia areata: a retrospective study with a self-controlled design. Ann Dermatol. 2013;25(1):12–16.
   PubMed Web of Science ®Google Scholar
• Royer M, Bodemer C, Vabres P, et al. Efficacy and tolerability of methotrexate in severe childhood alopecia areata. Br J Dermatol. 2011;165(2):407–410.
   PubMed Web of Science ®Google Scholar
• Lucas P, Bodemer C, Barbarot S, et al. Methotrexate in severe childhood alopecia areata: long-term follow-up. Acta Derm Venereol. 2016;96(1):102–103.
   PubMed Web of Science ®Google Scholar
• Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years’ experience at St John’s Institute of Dermatology. Br J Dermatol. 1995;133(60):914–918.
   PubMed Web of Science ®Google Scholar
• Mohamed Z, Bhouri A, Jallouli A, et al. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen. J Eur Acad Dermatol Venereol. 2005;19(5):552–555.
   PubMed Web of Science ®Google Scholar
• Al Mutairi N. 308-nm excimer laser for the treatment of alopecia areata in children. Pediatr Dermatol. 2009;26(5):547–550.
   PubMed Web of Science ®Google Scholar
• Xing L, Dai Z, Jabbari A, et al. Alopecia areata is driven by cytotoxic lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20(9):1043–1049.
   PubMed Web of Science ®Google Scholar
• Oranje AP, Peereboom-Wynia, JD, De Raeymaecker DM. Trichotillomania in childhood. J Am Acad Dermatol. 1996;15(4Pt1):614–619.
   Google Scholar
• Stroud JD. Hair loss in children. Pediatr Clin North Am. 1983;30(4):641–657.
   PubMed Web of Science ®Google Scholar
• Trichotillomania Learning Center [TLC] [Internet]. [cited 2016 Feb]. Available from: www.trich.org. 2016.
   Google Scholar
• Oranje AP, Novak J, Bilo RAC. Physiological habits, self-mutilation and factitious disorders. In: Irvine AD, Hoeger PH, Yan AC, editors. Harper’s textbook of pediatric dermatology. 3rd ed. Oxford (UK): Blackwell Publishing Ltd; 2011.
   Google Scholar
• Chandran NS, Novak J, Iorizzo M, et al. Trichotillomania in children. Skin Appendage Disorders. 2015;1:18–24.
   PubMed Web of Science ®Google Scholar
• Rogers K, Banis M, Falkenstein MJ, et al. Stepped care in the treatment of trichotillomania. J Consult Clin Psychol. 2014;82(2):361–367.
   PubMed Web of Science ®Google Scholar
• Heaton P. Habitual hair-pulling responsive to doll therapy. J Paediatr Child Health. 2009;45(5):318–319.
   PubMed Web of Science ®Google Scholar
• Boersma IH, Oranje AP. Trichotillomanie bij kinderen: een vaak gemiste diagnose [trichotillimania an often missed diagnosis]. Ned Tijdschr Geneeskd. 1992;136:355–358.
   PubMedGoogle Scholar
• Ghanizadeh A, Bazrafshan A, Firoozabadi A, et al. Habit reversal versus object manipulation training for treating nail biting: a randomized controlled clinical trial. Iran J Psychiatry. 2013;8(2):61–67.
   PubMedGoogle Scholar
• Lewin AB, Wu MS, Mc Guire JF, et al. Cognitive behavior therapy for obsessive-compulsive and related disorders. Pscyiatr Clin North Am. 2014;37(3):415–445.
   PubMed Web of Science ®Google Scholar
• Rothbart R, Stein DJ. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. Expert Opin Pharmacother. 2014;15(18):2709–2719.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Ung D, Selles RR, et al. Treating trichotillomania: a meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. J Psychiatr Res. 2014;58:76–83.
   PubMed Web of Science ®Google Scholar
• Grados MA, Atkins EB, Bovacikova GI, et al. A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders. Psychol Res Behav Manag. 2015;8:115–131.
   PubMed Web of Science ®Google Scholar
• Grant JE, Odlaug BL, Kim SW. N-Acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66:756–763.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Panza KE, Grant JE, et al. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. J Am Acad Child Adolesc Psychiatry. 2013;52(3):231–240.
   PubMed Web of Science ®Google Scholar
• Rothbart R, Amos T, Siegfried N, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2013;8:11.
   Google Scholar
• Toledo EL, De Togni Muniz E, Brito AM, et al. Group treatment for trichotillomania cognitive-behavioral therapy versus supportive therapy. J Clin Psychiatry. 2015;76(4):447–455.
   PubMed Web of Science ®Google Scholar